ANI Pharmaceuticals announced the results of the NEW DAY clinical trial for ILUVIEN® (fluocinolone acetonide) in diabetic macular edema (DME) patients during the ASRS Annual Scientific Meeting. The ...
Please provide your email address to receive an email when new articles are posted on . Consensus statements provide useful guidance on current clinical practice patterns and disease pathophysiology ...
ATLANTA, July 09, 2020 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company that specializes in the commercialization and development of prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results